|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.14 USD | +2.17% |
|
-3.22% | +5.68% |
| 06-23 | Deutsche Bank Initiates Coverage on DexCom With Buy Rating, $86 Price Target | MT |
| 06-17 | AI Can Play 'Significant' Role in Tech for Managing Diabetes, Says David Roman | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 27,065 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 4.56% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 26,660 | 25,854 | 24,844 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 1.72% | -3.02% | -3.91% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 28.7x | 24x | 20x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 9.9x | 8.5x | 6.48x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.7x | 1.2x | 1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 5.18x | 4.64x | 4.15x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 5.1x | 4.43x | 3.81x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 16.3x | 13.5x | 11.1x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 22x | 18x | 14.4x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 26.8x | 20.8x | 16.4x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.73% | 4.81% | 6.1% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.448 | 2.921 | 3.51 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,225 | 5,830 | 6,523 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,639 | 1,915 | 2,228 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,212 | 1,438 | 1,723 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 962.6 | 1,158 | 1,378 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -405 | -1,211 | -2,221 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 70.14 | 70.14 | 70.14 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 385,873 | - | - |
| Announcement Date | 10/2/22 | 9/2/23 | 8/2/24 | 13/2/25 | 12/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28.66x | 5.1x | 16.26x | -.--% | 27.07B | |
| 23.67x | 3.49x | 13.12x | 2.71% | 164B | |
| 18.48x | 3.22x | 11.33x | 3.66% | 104B | |
| 15.73x | 0.18x | 11.29x | 0.83% | 55.67B | |
| 32.33x | 7.85x | 20.51x | 1.24% | 52.92B | |
| 38.85x | 3.07x | 10.53x | 2.47% | 42.96B | |
| 37.21x | 1.36x | 11.99x | 0.21% | 32.87B | |
| 41.67x | 7.22x | 26.05x | 0.26% | 24.79B | |
| 23.73x | 3.47x | 12.47x | 1.22% | 21.02B | |
| 19.55x | 2.7x | 10.51x | 1.61% | 20.18B | |
| Average | 27.99x | 3.77x | 14.41x | 1.42% | 54.51B | |
| Weighted average by Cap. | 25.64x | 3.58x | 13.66x | 2.04% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
